Unishire Urban Infra appoints Nand Kishore Ray and Dheeraj Kumar as directors

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Unishire Urban Infra appointed Nand Kishore Ray and Dheeraj Kumar as Additional Directors on October 21, 2026
  • Ray joins as Executive and Non-Independent Director; Kumar joins as Executive Director
  • Both directors hold positions in Johnson Pharmacare Limited, with Ray chairing its SRC Committee
  • Board confirmed no familial relationships between new directors and existing management
powered bylight_fuzz_icon
54117440

*this image is generated using AI for illustrative purposes only.

Unishire Urban Infra Limited appointed Nand Kishore Ray and Dheeraj Kumar as Additional Directors of the company effective October 21, 2026. The appointments were approved by the Board of Directors during a meeting held on the same day.

Board meeting details

The Board of Directors convened at 1:00 pm and concluded at 1:30 pm on October 21, 2026. In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed the outcome of the meeting to BSE Limited.

Director profiles

Nand Kishore Ray (DIN: 11626638) has been appointed as an Additional Executive and Non-Independent Director. His profile indicates he holds a directorship in Johnson Pharmacare Limited and serves as Chairperson of its SRC Committee. He was born on January 1, 1956.

Dheeraj Kumar (DIN: 11666616) has been appointed as an Additional Executive Director. His profile notes that he is also a director in Johnson Pharmacare Limited, where he is a member of the Audit and Stakeholders Relationship Committee. He was born on January 1, 2005.

Director Name DIN Role Other Listed Directorship Committee Role in Other Company
Nand Kishore Ray 11626638 Executive & Non-Independent Johnson Pharmacare Limited Chairperson, SRC Committee
Dheeraj Kumar 11666616 Executive Johnson Pharmacare Limited Member, Audit & Stakeholders Relationship Committee

Compliance disclosures

Both appointees confirmed they are not related to any existing Directors or Key Managerial Personnel of Unishire Urban Infra. Additionally, neither director is debarred from holding office by SEBI or any other regulatory authority. The appointments are subject to confirmation by shareholders in accordance with applicable laws.

Historical Stock Returns for Unishire Urban Infra

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%+0.97%0.0%-31.58%0.0%-46.11%

How might the strategic expertise of the newly appointed directors from Johnson Pharmacare influence Unishire Urban Infra's future capital allocation or diversification strategies?

What specific operational changes or new project pipelines can investors expect as these Additional Directors transition into their executive roles?

Will the shareholder confirmation vote for these appointments face any resistance or require additional disclosure regarding potential related-party transactions?

Unishire Urban Infra FY26 net loss widens to ₹74.48 lacs

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Unishire Urban Infra reported a widened net loss of ₹74.48 lacs for FY26 compared to ₹1.50 lacs in FY25, with total income falling to ₹1,552.63 lacs. The statutory auditors, Arun Jain & Associates, issued an unmodified opinion on the standalone financial results.

powered bylight_fuzz_icon
41014994

*this image is generated using AI for illustrative purposes only.

Unishire Urban Infra Limited has reported its audited financial results for the financial year ended March 31, 2026. The board of directors approved the results during a meeting held on May 23, 2026. The company recorded a net loss of ₹74.48 lacs for the year, widening from a loss of ₹1.50 lacs in the previous fiscal year.

Total income for the year stood at ₹1,552.63 lacs, a decrease from ₹2,339.89 lacs in FY25. Total expenses for the period were reported at ₹1,622.42 lacs, compared to ₹2,341.39 lacs in the prior year. The basic and diluted earnings per share (EPS) for the year were (₹0.31), compared to (₹0.01) in the previous year.

Financial Performance Summary

Particulars Year Ended March 31, 2026 (₹ in lacs) Year Ended March 31, 2025 (₹ in lacs)
Total Income 1,552.63 2,339.89
Total Expenses 1,622.42 2,341.39
Net Profit/Loss (74.48) (1.50)
EPS (Basic) (0.31) (0.01)
Total Assets 3,992.58 2,139.91

The company's paid-up equity share capital remained unchanged at ₹2,435.85 lacs. Total assets as of March 31, 2026, were valued at ₹3,992.58 lacs, up from ₹2,139.91 lacs in the previous year. The trading window for the company's securities remains closed until 48 hours after the declaration of these results.

Audit Declaration

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company declared that the Independent Auditor's Report issued by Arun Jain & Associates, Chartered Accountants, on the Standalone Audited Financial Results for the financial year ended March 31, 2026, contains an unmodified opinion.

Historical Stock Returns for Unishire Urban Infra

1 Day5 Days1 Month6 Months1 Year5 Years
+0.97%+0.97%0.0%-31.58%0.0%-46.11%

What strategic initiatives is Unishire Urban Infra planning to reverse the revenue decline and return to profitability in FY27?

How does the significant increase in total assets from ₹2,139.91 lacs to ₹3,992.58 lacs align with the company's growth strategy, and what projects or acquisitions drove this expansion?

Given the widening net loss despite a substantial asset base, how will the company manage its liquidity and working capital requirements in the near term?

More News on Unishire Urban Infra

1 Year Returns:0.00%